Liminatus Pharma LIMN SEC Filings

NASDAQ LIMN
$3.12 -0.10 (-3.11%)
At close: Oct 21, 2026 · 4:00 PM EDT
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Liminatus Pharma, Inc. (LIMN) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001104659-26-111665Sep 29, 2026 9:15 AM
28-KCurrent Report0001104659-26-098335Aug 18, 2026 4:06 PM
310-QQuarterly & Annual Report0001104659-26-097304Aug 14, 2026 8:51 PM
48-KCurrent Report0001104659-26-090423Aug 4, 2026 8:30 PM
58-KCurrent Report0001104659-26-088380Jul 30, 2026 9:49 PM
68-KCurrent Report0001104659-26-086674Jul 24, 2026 8:51 PM
7SCHEDULE 13GBeneficial Ownership Report0001104659-26-085882Jul 22, 2026 9:07 PM
84Insider Transaction0001104659-26-083588Jul 14, 2026 9:46 PM
9SCHEDULE 13DBeneficial Ownership Report0001104659-26-083585Jul 14, 2026 9:36 PM
10DEF 14AOthers0001104659-26-082905Jul 13, 2026 12:43 PM
114Insider Transaction0001104659-26-080806Jul 6, 2026 8:59 PM
123Insider Transaction0001104659-26-080804Jul 6, 2026 8:57 PM
13SCHEDULE 13GBeneficial Ownership Report0001104659-26-080802Jul 6, 2026 8:56 PM
148-KCurrent Report0001104659-26-080613Jul 6, 2026 1:13 PM
15PRE 14AOthers0001104659-26-078994Jun 30, 2026 8:44 PM
16S-1Prospectus0001104659-26-076958Jun 24, 2026 1:28 AM
17DOthers0001104659-26-075732Jun 18, 2026 8:15 PM
188-KCurrent Report0001104659-26-070173Jun 3, 2026 5:14 PM
19424B3Prospectus0001104659-26-069843Jun 3, 2026 8:33 AM
208-KCurrent Report0001104659-26-066974May 27, 2026 4:30 PM-
218-KCurrent Report0001104659-26-064585May 20, 2026 9:00 PM
2210-QQuarterly & Annual Report0001104659-26-062734May 15, 2026 8:49 PM
2310-KQuarterly & Annual Report0001104659-26-037933Mar 31, 2026 5:28 PM
2410-KQuarterly & Annual Report0001104659-26-037933Mar 31, 2026 5:28 PM
2510-KQuarterly & Annual Report0001104659-26-037933Mar 31, 2026 5:28 PM
268-KCurrent Report0001104659-26-023467Mar 4, 2026 4:15 PM
27SCHEDULE 13GBeneficial Ownership Report0001213900-26-018820Feb 20, 2026 4:15 PM
288-KCurrent Report0001104659-26-017134Feb 18, 2026 5:13 PM
29424B4Prospectus0001104659-26-016706Feb 18, 2026 6:02 AM
30EFFECTOthers9999999995-26-000587Feb 13, 2026 12:15 AM
31S-1Prospectus0001104659-26-012942Feb 11, 2026 6:08 AM
328-KCurrent Report0001104659-26-012016Feb 9, 2026 3:01 PM
338-KCurrent Report0001104659-26-006619Jan 26, 2026 4:31 PM
34DRSOthers0001104659-25-125670Dec 31, 2025 5:27 PM
358-KCurrent Report0001104659-25-116049Nov 25, 2025 5:26 PM
3610-QQuarterly & Annual Report0001104659-25-111651Nov 14, 2025 9:01 PM
3710-QQuarterly & Annual Report0001104659-25-096872Oct 6, 2025 9:53 PM
388-KCurrent Report0001104659-25-082579Aug 25, 2025 5:15 PM
393Insider Transaction0001200876-25-000042Aug 15, 2025 2:50 PM
403Insider Transaction0001200876-25-000042Aug 15, 2025 2:50 PM
413Insider Transaction0001200876-25-000042Aug 15, 2025 2:50 PM
42NT 10-QQuarterly & Annual Report0001104659-25-078852Aug 15, 2025 8:08 PM
438-KCurrent Report0001104659-25-078577Aug 14, 2025 4:06 PM
44424B3Prospectus0001410578-25-001746Aug 13, 2025 4:30 PM
45EFFECTOthers9999999995-25-002576Aug 12, 2025 12:15 AM
46CORRESPOthers0001104659-25-076067Aug 11, 2025 12:00 PM
47S-1Prospectus0001410578-25-001518Jul 28, 2025 9:59 PM
48CORRESPOthers0001104659-25-070940Jul 25, 2025 9:58 PM
493Insider Transaction0001104659-25-069941Jul 23, 2025 2:19 PM
503Insider Transaction0001104659-25-069941Jul 23, 2025 2:19 PM

Liminatus Pharma, Inc. SEC Filings API

Pull Liminatus Pharma, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=LIMN&formtype=10-K,10-Q&api_key=YOUR_API_KEY